Dermatop

Dermatop is a brand name of prednicarbate topical, approved by the FDA in the following formulation(s):

DERMATOP (prednicarbate - ointment; topical)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: September 23, 1991
  
  Strength(s): 0.1% ^[RLD][AB]

Has a generic version of Dermatop been approved?

Yes. The following products are equivalent to Dermatop:

prednicarbate ointment; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: March 9, 2007
  
  Strength(s): 0.1% ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dermatop. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Dermatop.

See also...

• Dermatop Cream Consumer Information (Wolters Kluwer)
• Dermatop Ointment Consumer Information (Wolters Kluwer)
• Dermatop Consumer Information (Cerner Multum)
• Dermatop Advanced Consumer Information (Micromedex)
• Dermatop E Advanced Consumer Information (Micromedex)
• Dermatop AHFS DI Monographs (ASHP)
• Prednicarbate Cream Consumer Information (Wolters Kluwer)
• Prednicarbate Ointment Consumer Information (Wolters Kluwer)
• Prednicarbate topical Consumer Information (Cerner Multum)
• Prednicarbate Topical application Advanced Consumer Information (Micromedex)
• Prednicarbate AHFS DI Monographs (ASHP)